Related Experiment Videos
Comments on article by C. Sternberg. Eur J Cancer 2002, 38, 460-467
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
When to Hold and When to Fold: The Clinical Approach to Locoregional Recurrence After Curative Treatment of Solid Cancers.
Clinical oncology (Royal College of Radiologists (Great Britain))·2025
Technical Aspects of a National Service for Paediatric Pelvic Brachytherapy.
Clinical oncology (Royal College of Radiologists (Great Britain))·2024
The Use of Artificial Intelligence Technologies in Cancer Care.
Clinical oncology (Royal College of Radiologists (Great Britain))·2024
Functional Magnetic Resonance Imaging in Cervical Cancer Diagnosis and Treatment.
Clinical oncology (Royal College of Radiologists (Great Britain))·2023
A National Referral Service for Paediatric Brachytherapy: An Evolving Practice and Outcomes Over 13 Years.
Clinical oncology (Royal College of Radiologists (Great Britain))·2023
Natural history and treatment outcomes in aggressive angiomyxoma: A single institution experience.
European journal of cancer (Oxford, England : 1990)·2026
Diagnostic pitfalls and unmet needs in neuroendocrine neoplasms: The added value of collegial expert pathology review through the national TENpath network.
European journal of cancer (Oxford, England : 1990)·2026
Twenty-five years survival of primary central nervous system lymphomas treated with the C5R regimen.
European journal of cancer (Oxford, England : 1990)·2026
Broad baseline-variable profiling of visceral conversion in bone-only HR+/HER2 - metastatic breast cancer treated with CDK4/6 inhibitors.
European journal of cancer (Oxford, England : 1990)·2026
Development of an age specific EORTC questionnaire to assess the health-related quality of life (HRQOL) of children with cancer aged 8-14 years - a mixed-methods content elicitation phase I & II EORTC QLG study.
European journal of cancer (Oxford, England : 1990)·2026
Lenvatinib plus pembrolizumab for the treatment of patients with non-BRAF mutated anaplastic thyroid cancer: A single center, phase 2 clinical trial.
European journal of cancer (Oxford, England : 1990)·2026